Choline Bitartrate Market - By Type (L-Type, D-Type, DL-Type), By Application (Pharmaceutical & Nutritional Supplement, Baby Food, Food & Beverage) & Forecast, 2022-2028

Choline Bitartrate Market Size

Choline Bitartrate Market size exceeded USD 410 million in 2021 and is estimated to grow at over 6% CAGR between 2022 and 2028. Choline bitartrate is an active pharmaceutical ingredient formed by the mixture of choline and tartaric acid. Choline is an essential nutrient precursor to acetylcholine. It helps in synthesis of sphingomyelin and phosphatidylcholine which major constitutes of cell membrane. Choline bitartrate plays an important role in lipid transportation, supports cell membrane, healthy metabolism, DNA synthesis and early brain development.
 

Choline bitartrate is used in place of natural choline as it is easily digestible and has better immersion rate. There are three types of choline bitartrate namely choline d-bitartrate, choline l-bitartrate and choline dl-bitartrate. Increasing acceptance of it in infant formula, dietary supplements, fortified food & beverage industry is expected to drive choline bitartrate market demand. Rising awareness regarding essential nutrition and growing emphasis on preventive health care will propel the demand for choline bitartrate in upcoming years.
 

Covid-19 pandemic enforced manufacturing units and factories to shut down temporarily this factor significantly hampered manufacturing operations of the choline bitartrate market. However, as food & beverages, pharmaceuticals, and nutritional supplements were considered as an essential commodity, their production continued during pandemic by taking precautionary measures. This factor caused a demand and supply gap between manufacturers and raw material suppliers which affected the overall market growth.
 

Various regulations and standard specifications for the quality, labelling, advertisement, and formulation, of choline bitartrate for the usage in food products is anticipated to hinder the market growth at some extend. For instance, EU (EU) No 609/2013 prohibits the use of infant’s pictures for presentations, packaging and advertising of infant formula. It also states that any text or picture should not idealize use of such formula. Advertising and labeling for infant formula should be designed in such a way that it does not discourage breast-feeding.
 

Choline Bitartrate Market Analysis

DL-Type choline bitartrate market surpassed USD 150 million in 2021 and is anticipated to register over 6.5% CAGR in the forecast period. DL-Type choline bitartrate is formed by combination of DL-tartaric acid and choline. It is mostly used in manufacturing of dietary supplements. DL-Type choline bitartrate supplements helps in overcoming choline deficiency which causes liver diseases and muscle damage.
 

Health benefits of choline bitartrate such as supporting of brain health, reducing fatigue, increasing energy and endurance, overcoming depression, raising cognitive performance is driving the usage of DL-type choline bitartrate in supplements. After the outbreak of Covid-19 pandemic people have become more concerned about their physical and mental wellness. This factor coupled with rising consumer awareness is expected to drive demand for DL-type choline bitartrate in the forecast period.
 

Choline bitartrate ensures proper development of fetus and lowers risk of birth defects; owing to this, doctors often prescribe choline bitartrate-based supplements to pregnant woman. Choline moves fats out from liver and convert it into energy, its usage as an energy boosting supplement is also increasing its demand in sports industry. Intensive physical activities reduce choline levels in the body, which cause fat to build up on muscle and liver cells. To overcome this, athletes are increasingly preferring choline bitartrate supplements, thus propelling market statistics.
 

Choline bitartrate market from baby food application segment is anticipated to reach over USD 185 million by 2028. Choline bitartrate plays an important role in brain development owing to this its application in manufacturing baby food is surging. Choline bitartrate also ensures healthy growth of babies, due to which it is added to infant formulation and cereals thus accelerating market statistics.
 

Choline bitartrate is used in manufacturing organic and fortified organic baby foods as they improve visuospatial memory in a child. During initial developments of children millions of cells grow and as choline helps in improving messaging between cell and supporting cell membrane it plays an important role during early child growth. As there are multiple health benefits of choline bitartrate for babies its application in baby food is expected to propel the overall market demand during forecast period.
 

Growing concerns towards newborn babies’ health, rising number of working mothers, increasing disposable income, economic development and growing population is expected to increase demand for infant formulation which in turn is expected to accelerate demand for choline bitartrate market. Rising demand for chemical free, natural, and organic infant formulation is also expected to propel the market outlook.
 

North America choline bitartrate market is anticipated to surpass USD 215 million by 2028. North America is the dominating region owing to the presence of large number of pharmaceutical and nutraceutical companies.
 

Additionally, due to sedentary lifestyle, high disposable income, ageing population and rising chronic diseases North America is the largest consumer of dietary supplements. More than 75% of US adults take dietary supplement. As North America has well established supplements industry and producer of choline bitartrate itself the products are cost effective and exported to other countries.
 

Changing lifestyle due to the hectic and busy schedule, have raised the demand for packaged food and beverages in the region. Packaged food and beverages are cost-effective, quick, and convenient to consume owing to this its popularity is growing rapidly among young population in North America, this factor is also proving positive for the regional market expansion.
 

Choline Bitartrate Market Share

The global choline bitartrate market is fragmented in nature with presence of both large and small manufacturers.

• Balchem Inc
• Glentham Life Sciences Limited
• Cepham Life Sciences
• Finetech Industry Limited
• Arochem Industries
• Salvi Chemical Industries Ltd
• Alfa Aesar
• Jinan Pengbo Biotechnology Co., Ltd.
• NutriScience Innovations, LLC
• TCI Chemicals (India) Pvt. Ltd.

are few manufacturers present in the market.
 

Manufacturers are continuously investing in R&D to improve quality and transparency in manufacturing. Key players are also engaged in strategic initiatives such as capacity expansion, merger, and acquisition to expand its foothold in industry and increase its market share in the foreseeable timeframe.
 

The Global Choline Bitartrate Market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in kilo tons & revenue in USD million from 2017 to 2028 for the following segments.

By Type

• L-Type
• D-Type
• DL-Type

By Application

• Pharmaceutical & Nutritional Supplement
• Food & Beverage
• Baby Food
• Others

The above information has been provided for the following region:

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Switzerland
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Thailand
  • Australia
• Latin America
  • Brazil
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE